Navigation Links
International Animal/Veterinary Vaccines Market 2013-2018
Date:12/26/2013

DUBLIN, December 26, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/qv4xvl/animalveterinary) has announced the addition of the "International Animal/Veterinary Vaccines Market 2013-2018" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

 

Europe accounts for the largest share of the veterinary vaccines market, followed by North America. Both markets are reaching the maturity phase of growth and will register mid single-digit growth rates for the next five years. Asia, parts of Africa, and LATAM are poised to grow at double-digit rates owing to the increasing investment opportunities for companies in these immature markets and due to the improving healthcare facilities for animals. Countries like China, India, Australia, and Brazil will be major contributors to the growth of the market.

The market is dominated by tier I players and is fairly consolidated with the top 5 players contributing close to 70% of the share. New entrants face high barriers in entering this market as it is a capital-intensive industry with strict regulations.

This research report categorizes the global animal/veterinary vaccines market on the basis of products, animal diseases, and technology. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2011, 2012, and 2013 as well as forecasts up to 2018. Each segment of the market is comprehensively analyzed at a granular level, by geography (Europe, North America, Asia, and the Rest of the World), to provide in-depth information on the global scenario.

Key Topics Covered:

1 Introduction
1.1 Key Take-Aways
1.2 Report Description
1.3 Research Methodology
1.4 Markets Covered
1.5 Stakeholders
1.6 Market Scope

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.4 Regulations For Animal Vaccines
3.5 Porter's Five Forces Analysis
3.6 Market Share Analysis of Animal Vaccines

4 Global Animal Vaccines Market, By Product
4.1 Introduction
4.2 Companion Animal Vaccines
4.3 Livestock Vaccines
4.4 Poultry Vaccines
4.5 Porcine Vaccines
4.6 Equine Vaccines
4.7 Aquaculture Vaccines
4.8 Other Animal Vaccines

5 Global Animal Vaccines Market, By Disease
5.1 Introduction
5.2 Companion Animal Vaccines
5.3 Livestock Vaccines
5.4 Poultry Vaccines, By Disease
5.5 Porcine Vaccines, By Disease
5.6 Equine Vaccines, By Disease
5.7 Aquaculture Vaccines, By Disease

6 Animal Vaccines Market, By Technology
6.1 Introduction
6.2 Live Attenuated Vaccines (LAV)
6.3 Inactivated Vaccines
6.4 Subunit Vaccines
6.5 Toxoid Vaccines
6.6 Conjugate Vaccines
6.7 Recombinant Vaccines
6.8 Dna Vaccines
6.9 Live Attenuated Technology Contributes The Largest To The Livestock Vaccines Market
6.10 Dna Vaccines Along With Inactivated & Recombinant Technology To Grow At Healthy Pace
6.11 Inactivated Vaccines Technology Accounts For The Largest Share In Porcine Vaccine Market

7 Geographic Analysis
7.1 Introduction
7.2 Europe
7.3 North America
7.4 Asia
7.5 Rest Of The World (ROW)

8 Competitive Landscape
8.1 Introduction
8.2 Mergers & Acquisitions
8.3 Agreements, Partnerships, Collaborations, & Joint Ventures
8.4 New Product Launch
8.5 Other Developments

9 Company Profiles


Companies Mentioned:

  • Bayer Healthcare
  • Biogenesis Bago SA
  • Bioniche Animal Health Canada, Inc
  • Boehringer Ingelheim
  • Ceva (Ceva Sante Animale)
  • Heska Corporation
  • Indian Immunologicals Ltd
  • Lohmann Animal Health International
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Novartis Animal Health, Inc
  • Protein Sciences Corporation
  • Virbac
  • Zoetis

For more information visit http://www.researchandmarkets.com/research/qv4xvl/animalveterinary


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
4. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
6. Chindex International, Inc. to Report First Quarter 2012 Financial Results
7. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
8. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
9. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
10. Bacterin International Signs Its Third National GPO Contract with Novation
11. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... 27, 2017  Sanderling Ventures, portfolio company, Torax ... division of Johnson & Johnson. Torax manufactures and markets ... of gastro-esophageal reflux disease (GERD). The LINK device ... and the procedure is currently available in the ... Medical was founded by Sanderling Ventures, Mayo Medical ...
(Date:3/27/2017)... AVIV, Israel , March 27, 2017 ... on oncology and immunology, announced today that AGI-134, an immunotherapy ... announced acquisition of Agalimmune Ltd., will be featured at the ... in Washington, DC to be ... ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the appropriate ... and maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO ... " these requirements are explained. The challenge is to determine how to ...
(Date:3/28/2017)... ... 2017 , ... Neurotechnology , a provider of high-precision ... tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the updated  ... recognition to enable users to check in and out from anywhere via the ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... ... March 28, 2017 , ... A ... achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing ... should be aware of when utilizing dental laboratories and technicians that create these ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):